Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20010010819A1
SERIAL NO

09782290

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of TNF antagonists for producing drugs for the treatment of disorders characterized by elevated serum levels of interleukin-6.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KNOLL AKTIENGESELLSCHAFTD-67061 LUDWIGSHAFEN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Daum, Lothar Otterstadt, DE 8 345
Kaul, Martin Neustadt, DE 11 305
Kempeni, Joachim Neustadt, DE 19 588
Raab, Christa Dannstadt-Schauernheim, DE 2 144
Schaefer, Sibylle Walldorf, DE 2 144
Stenzel, Roswitha Lampertheim, DE 2 144

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation